NBI-27914
NBI-27914 is a potent and selective antagonist of CRFR1. The CRF receptors, CRFR1 and CRFR2, are members of the G protein-coupled receptor superfamily[1].
Product Specifications
CAS Number
[184241-44-9]
UNSPSC
12352005
Hazard Statement
H315, H319, H335
Target
CRFR
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/nbi-27914.html
Purity
99.94
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
ClC1=C(NC2=C(Cl)C(N(CC3CC3)CCC)=NC(C)=N2)C(Cl)=CC(Cl)=C1
Molecular Formula
C18H20Cl4N4
Molecular Weight
434.19
Precautions
H315, H319, H335
References & Citations
[1]Liaw CW, et al. Localization of agonist- and antagonist-binding domains of human corticotropin-releasing factor receptors. Mol Endocrinol. 1997;11 (13) :2048-2053.
Shipping Conditions
Room Temperature
Storage Conditions
4°C (Powder, sealed storage, away from moisture)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
211089-01 50 µL
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
Ask
View Details 211089-02 100 µL
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
Ask
View Details 
211089-03 200 µL
GRHPR (Glyoxylate Reductase/Hydroxypyruvate Reductase, PH2, GLXR, GLYD) discontinued
Ask
View Details